Correction to: Adv Therapy 34:221–235 https://doi.org/10.1007/s12325-016-0448-9
In the original article, the incorrect Open Access License type has been included. The correct open access license type is given below.
This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and Adv Ther indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/bync/4.0/.
The original article has been corrected.
About this article
Cite this article
Konstas, AG., Boboridis, K.G., Kapis, P. et al. Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy. Adv Ther 37, 2572–2573 (2020). https://doi.org/10.1007/s12325-020-01316-y